Journal
CURRENT OPINION IN INFECTIOUS DISEASES
Volume 22, Issue 2, Pages 154-158Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/QCO.0b013e328322a006
Keywords
aerosol; aminoglycosides; antimicrobial treatment; nosocomial pneumonia
Categories
Ask authors/readers for more resources
Purpose of review This review summarizes the recent data on antibiotic aerosolization to treat ventilator-associated pneumonia. Recent findings Most studies on antibiotic aerosolization have been case reports or descriptive studies, The results of a recent randomized, placebo-controlled trial indicated that adjunctive use of nebulized antibiotic with intravenous antibiotics to treat purulent tracheobronchitis was associated with a better outcome than placebo aerosolization. A randomized study, so far published only as an abstract, showed that amikacin aerosolized with a vibrating-mesh nebulizer - a new-generation device - was well distributed in the lung parenchyma and might lead to less intravenous antibiotic use. Several thorough reviews on nebulization devices. techniques and drawbacks have been published recently. Summary Despite recent promising findings, the widespread use of aerosolized antibiotics to treat ventilator-associated pneumonia cannot be recommended. It should be restricted to the treatment of multidrug-resistant Gram-negative ventilator-associated pneumonia.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available